Astrana Health, Inc.
ASTH
$37.85
$0.471.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 52.43% | -32.38% | |||
| Total Other Revenue | 0.98% | -0.06% | |||
| Total Revenue | 1.53% | -0.58% | |||
| Cost of Revenue | 0.45% | -0.39% | |||
| Gross Profit | 11.26% | -2.21% | |||
| SG&A Expenses | 1.13% | 17.20% | |||
| Depreciation & Amortization | -5.62% | 5.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.39% | 0.69% | |||
| Operating Income | 62.14% | -40.38% | |||
| Income Before Tax | 162.58% | 32.36% | |||
| Income Tax Expenses | 596.82% | -79.45% | |||
| Earnings from Continuing Operations | 100.11% | 509.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 331.79% | 20.03% | |||
| Net Income | 140.64% | 1,508.31% | |||
| EBIT | 62.14% | -40.38% | |||
| EBITDA | 29.45% | -24.63% | |||
| EPS Basic | 146.10% | 1,503.95% | |||
| Normalized Basic EPS | 1,378.02% | -90.85% | |||
| EPS Diluted | 137.90% | 1,503.95% | |||
| Normalized Diluted EPS | 1,337.02% | -90.84% | |||
| Average Basic Shares Outstanding | -2.26% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.98% | -- | |||